189 related articles for article (PubMed ID: 11428627)
21. Putative role of proteolysis and inflammatory response in the toxicity of nerve and blister chemical warfare agents: implications for multi-threat medical countermeasures.
Cowan FM; Broomfield CA; Lenz DE; Smith WJ
J Appl Toxicol; 2003; 23(3):177-86. PubMed ID: 12794939
[TBL] [Abstract][Full Text] [Related]
22. Novel endogenous inhibitor of sulfur mustard-stimulated protease in cultured human epidermal keratinocytes: possible application in vesicant intervention.
Chakrabarti AK; Ray P
J Appl Toxicol; 2000 Dec; 20 Suppl 1():S59-61. PubMed ID: 11428644
[TBL] [Abstract][Full Text] [Related]
23. Ocular injuries following sulfur mustard exposure--pathological mechanism and potential therapy.
Kadar T; Dachir S; Cohen L; Sahar R; Fishbine E; Cohen M; Turetz J; Gutman H; Buch H; Brandeis R; Horwitz V; Solomon A; Amir A
Toxicology; 2009 Sep; 263(1):59-69. PubMed ID: 19061933
[TBL] [Abstract][Full Text] [Related]
24. Protective effect of povidone iodine ointment against skin lesions induced by chemical and thermal stimuli.
Wormser U; Brodsky B; Green BS; Arad-Yellin R; Nyska A
J Appl Toxicol; 2000 Dec; 20 Suppl 1():S183-5. PubMed ID: 11428633
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous protease activity in the mouse ear vesicant model.
Powers JC; Kam CM; Ricketts KM; Casillas RP
J Appl Toxicol; 2000 Dec; 20 Suppl 1():S177-82. PubMed ID: 11428632
[TBL] [Abstract][Full Text] [Related]
26. Response of normal human keratinocytes to sulfur mustard: cytokine release.
Arroyo CM; Schafer RJ; Kurt EM; Broomfield CA; Carmichael AJ
J Appl Toxicol; 2000 Dec; 20 Suppl 1():S63-72. PubMed ID: 11428645
[TBL] [Abstract][Full Text] [Related]
27. Sulfur mustard induces an endoplasmic reticulum stress response in the mouse ear vesicant model.
Chang YC; Wang JD; Svoboda KK; Casillas RP; Laskin JD; Gordon MK; Gerecke DR
Toxicol Appl Pharmacol; 2013 Apr; 268(2):178-87. PubMed ID: 23357548
[TBL] [Abstract][Full Text] [Related]
28. Selection of non-steroidal anti-inflammatory drug and treatment regimen for sulfur mustard-induced cutaneous lesions.
Plahovinsak JL; Buccellato MA; Reid FM; Graham JS
Cutan Ocul Toxicol; 2016 Sep; 35(3):208-17. PubMed ID: 26362124
[TBL] [Abstract][Full Text] [Related]
29. Effects of anti-inflammatory compounds on sulfur mustard injured cells: Recommendations and caveats suggested by in vitro cell culture models.
Menacher G; Steinritz D; Schmidt A; Popp T; Worek F; Gudermann T; Thiermann H; Balszuweit F
Toxicol Lett; 2018 Sep; 293():91-97. PubMed ID: 28916287
[TBL] [Abstract][Full Text] [Related]
30. Sulfur mustard-induced skin burns in weanling swine evaluated clinically and histopathologically.
Reid FM; Graham J; Niemuth NA; Singer AW; Janny SJ; Johnson JB
J Appl Toxicol; 2000 Dec; 20 Suppl 1():S153-60. PubMed ID: 11428629
[TBL] [Abstract][Full Text] [Related]
31. Biochemical changes in mouse lung after subcutaneous injection of the sulfur mustard 2-chloroethyl 4-chlorobutyl sulfide.
Elsayed NM; Omaye ST
Toxicology; 2004 Jul; 199(2-3):195-206. PubMed ID: 15147793
[TBL] [Abstract][Full Text] [Related]
32. Ultrastructural characterization of sulfur mustard-induced vesication in isolated perfused porcine skin.
Monteiro-Riviere NA; Inman AO
Microsc Res Tech; 1997 May; 37(3):229-41. PubMed ID: 9144635
[TBL] [Abstract][Full Text] [Related]
33. Suppression of sulfur mustard-increased IL-8 in human keratinocyte cell cultures by serine protease inhibitors: implications for toxicity and medical countermeasures.
Cowan FM; Broomfield CA; Smith WJ
Cell Biol Toxicol; 2002; 18(3):175-80. PubMed ID: 12083423
[TBL] [Abstract][Full Text] [Related]
34. Histopathologic features seen with different animal models following cutaneous sulfur mustard exposure.
Smith KJ; Casillas R; Graham J; Skelton HG; Stemler F; Hackley BE
J Dermatol Sci; 1997 Feb; 14(2):126-35. PubMed ID: 9039976
[TBL] [Abstract][Full Text] [Related]
35. Treatment of skin injuries induced by sulfur mustard with calmodulin antagonists, using the pig model.
Kadar T; Fishbeine E; Meshulam Y; Sahar R; Chapman S; Liani H; Barness I; Amir A
J Appl Toxicol; 2000 Dec; 20 Suppl 1():S133-6. PubMed ID: 11428625
[TBL] [Abstract][Full Text] [Related]
36. Comparison of cell size in sulfur mustard-induced death of keratinocytes and lymphocytes.
Moser J; Meier HL
J Appl Toxicol; 2000 Dec; 20 Suppl 1():S23-30. PubMed ID: 11428638
[TBL] [Abstract][Full Text] [Related]
37. Sulfur mustard induced mast cell degranulation in mouse skin is inhibited by a novel anti-inflammatory and anticholinergic bifunctional prodrug.
Joseph LB; Composto GM; Perez RM; Kim HD; Casillas RP; Heindel ND; Young SC; Lacey CJ; Saxena J; Guillon CD; Croutch CR; Laskin JD; Heck DE
Toxicol Lett; 2018 Sep; 293():77-81. PubMed ID: 29127031
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic potential of a non-steroidal bifunctional anti-inflammatory and anti-cholinergic agent against skin injury induced by sulfur mustard.
Chang YC; Wang JD; Hahn RA; Gordon MK; Joseph LB; Heck DE; Heindel ND; Young SC; Sinko PJ; Casillas RP; Laskin JD; Laskin DL; Gerecke DR
Toxicol Appl Pharmacol; 2014 Oct; 280(2):236-44. PubMed ID: 25127551
[TBL] [Abstract][Full Text] [Related]
39. Acute ocular effects of mustard gas: ultrastructural pathology and immunohistopathology of exposed rabbit cornea.
Petrali JP; Dick EJ; Brozetti JJ; Hamilton TA; Finger AV
J Appl Toxicol; 2000 Dec; 20 Suppl 1():S173-5. PubMed ID: 11428631
[TBL] [Abstract][Full Text] [Related]
40. Hairless guinea pig bioassay model for vesicant vapor exposures.
Mershon MM; Mitcheltree LW; Petrali JP; Braue EH; Wade JV
Fundam Appl Toxicol; 1990 Oct; 15(3):622-30. PubMed ID: 2258024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
